Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2009

01.08.2009 | Epidemiology

Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme

verfasst von: Sylvia B. F. Brown, David S. Morrison, Timothy G. Cooke

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

The incidence of breast cancer in post-menopausal women has been affected by the introduction of national breast screening programmes. The study describes the incidence of breast cancer in Scottish women aged 50–64 by year of birth before, during, and after the prevalent round of screening. Breast cancer registrations in Scotland for women aged 45–69 years from 1977 to 2003 were obtained. Birth cohort incidence rates were calculated and interpreted in the light of screening patterns at particular calendar time points. In the years before screening, there was a small rise in breast cancer incidence by birth cohort in women aged 50–54 which was not seen in other ages. During the prevalent screening round, incidence increased significantly with increasing birth cohort and thereafter continued rises in incidence by birth cohort occurred. The observed rise in breast cancer incidence among post-menopausal women is likely to be due to both screening effects and a true increase in incidence.
Literatur
1.
Zurück zum Zitat Breast cancer incidence data (2005) Scottish Executive Information & Statistics Division, Scotland Breast cancer incidence data (2005) Scottish Executive Information & Statistics Division, Scotland
2.
Zurück zum Zitat Brown SBF, Hole DJ, Cooke TG (2006) Breast cancer incidence trends in deprived and affluent Scottish women. Breast Cancer Res Treat 103(2):233–238PubMedCrossRef Brown SBF, Hole DJ, Cooke TG (2006) Breast cancer incidence trends in deprived and affluent Scottish women. Breast Cancer Res Treat 103(2):233–238PubMedCrossRef
3.
Zurück zum Zitat Swerdlow AJ, dos Santos Silva I, Reid A, Qiao Z, Brewster DH, Arrundale J (1998) Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer 77(Suppl 3):1–54PubMed Swerdlow AJ, dos Santos Silva I, Reid A, Qiao Z, Brewster DH, Arrundale J (1998) Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer 77(Suppl 3):1–54PubMed
5.
Zurück zum Zitat Schouten LJ, de Rijke JM, Huveneers JA, Verbeek AL (2002) Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme. J Med Screen 9:120–124. doi:10.1136/jms.9.3.120 PubMedCrossRef Schouten LJ, de Rijke JM, Huveneers JA, Verbeek AL (2002) Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme. J Med Screen 9:120–124. doi:10.​1136/​jms.​9.​3.​120 PubMedCrossRef
6.
Zurück zum Zitat Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO et al (2005) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113:302–306. doi:10.1002/ijc.20561 PubMedCrossRef Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO et al (2005) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113:302–306. doi:10.​1002/​ijc.​20561 PubMedCrossRef
8.
Zurück zum Zitat Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol 139:819–835PubMed Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol 139:819–835PubMed
9.
Zurück zum Zitat Pathak DR, Whittemore AS (1992) Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol 135:153–168PubMed Pathak DR, Whittemore AS (1992) Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol 135:153–168PubMed
10.
Zurück zum Zitat Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303:767–770. doi:10.1038/303767a0 PubMedCrossRef Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303:767–770. doi:10.​1038/​303767a0 PubMedCrossRef
12.
Zurück zum Zitat Newcombe RG, Altman DG (2000) Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner S (eds) Statistics with confidence, Ch 6, 2nd edn. BMJ Books, London Newcombe RG, Altman DG (2000) Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner S (eds) Statistics with confidence, Ch 6, 2nd edn. BMJ Books, London
13.
Zurück zum Zitat dos Santos Silva I, Swerdlow AJ (1995) Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 72:485–492PubMed dos Santos Silva I, Swerdlow AJ (1995) Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 72:485–492PubMed
14.
Zurück zum Zitat Cumulative fertility data at age 44 by maternal birth cohort (2006) General Register Office-Scotland Cumulative fertility data at age 44 by maternal birth cohort (2006) General Register Office-Scotland
15.
Zurück zum Zitat Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674. doi:10.1056/NEJMsr070105 PubMedCrossRef Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674. doi:10.​1056/​NEJMsr070105 PubMedCrossRef
17.
Zurück zum Zitat Townsend J (1998) Hormone replacement therapy: assessment of present use, costs, and trends. Br J Gen Pract 48:955–958PubMed Townsend J (1998) Hormone replacement therapy: assessment of present use, costs, and trends. Br J Gen Pract 48:955–958PubMed
18.
Zurück zum Zitat Townsend J, Nanchahal K (2005) Hormone replacement therapy: limited response in the UK to the new evidence. Br J Gen Pract 55:555PubMed Townsend J, Nanchahal K (2005) Hormone replacement therapy: limited response in the UK to the new evidence. Br J Gen Pract 55:555PubMed
Metadaten
Titel
Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme
verfasst von
Sylvia B. F. Brown
David S. Morrison
Timothy G. Cooke
Publikationsdatum
01.08.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0205-0

Weitere Artikel der Ausgabe 3/2009

Breast Cancer Research and Treatment 3/2009 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.